Skip to main content
. 2018 Oct 15;28(19):3255–3259. doi: 10.1016/j.bmcl.2018.07.044

Table 3.

Effect of R1 substitution on kinetic aqueous solubility and human plasma stability.

graphic file with name fx3.jpg

Compound R1 H Plasma Stability (half-life min)a Kinetic solubility (µM)b CHI logDc H Skin S9 (half-life min)d S1PR1 pIC50e
11 OH >180 <6 (0)
12d graphic file with name fx4.gif 180 117 3.0 152
12e graphic file with name fx5.gif 61 79 2.8 40
12f graphic file with name fx6.gif 9 79 3.3 23 <6 (0)
a

Incubated in human plasma at 37 °C.

b

The aqueous solubility of the test compounds was measured using laser nephelometry.

c

Reverse-phase HPLC method to determine the chromatographic hydrophobicity index (CHI).

d

Stability measured in skin S9 over 180 mins in the presence of enzymatic cofactors.

e

All pIC50s reported in this table correspond to n of 2, reported as their geometric mean. The range of pIC50 values is provided in brackets.